BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD. - Submission Of Unaudited Quarterly Financial Results For The Quarter And Nine Months Ended December 2022 Along With Limited Review Report
10 Feb 2023
In compliance of SEBI LODR with Stock Exchange, please find enclosed the Unaudited Quarterly Financial Results for the quarter and nine months ended December 2022 along with Limited Review Report, approved by the Board of the Company in its Meeting held on 09.02.2023.
Source:
BSE India